FCH
DTIL icon

Freestone Capital Holdings’s Precision BioSciences DTIL Stock Holding History

Freestone Capital Holdings’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27
Closed -$6.67K – 576
2020
Q4 		$6.67K Hold
27
– – ﹤0.01% 936
2020
Q3 		$4.93K Buy
+27
New +$5.37K ﹤0.01% 884

Other funds holding DTIL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Freestone Capital Holdings's DTIL Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Precision BioSciences (DTIL) in Q1 2021, closing a stake of 27 shares — an estimated $6.67K sold.

Freestone Capital Holdings first reported a position in DTIL in Q3 2020 and held it in 2 quarters. The position peaked at $6.67K in Q4 2020. 128 funds tracked by Wall St. Rank hold DTIL as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Precision BioSciences position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 27 Precision BioSciences shares in Q1 2021, an estimated $6.67K.
  • Freestone Capital Holdings first reported a position in Precision BioSciences in Q3 2020 and held it in 2 quarters.
  • Freestone Capital Holdings's Precision BioSciences position peaked at $6.67K in Q4 2020.
  • 128 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.